ORLANDO, Fla., Aug. 30, 2013 /PRNewswire/ -- Orlando-based nutraceutical company XYMOGEN has announced a 2013-2014 seminar series, The Metabolic Nexus. The event series, which features presentations from healthcare industry pioneers, aims to bridge the knowledge gap between patients and healthcare professionals.
The Metabolic Nexus includes engaging and educational presentations by renowned XYMOGEN practitioners David Perlmutter, M.D., F.A.C.N., and Paul Nemiroff, Ph.D., M.D., F.A.C.S., who will lead discussions on achieving optimal brain and joint health. XYMOGEN plans for attendees to walk away with a stronger idea of the shifts in scientific thinking and an altered perspective on healthcare.
"XYMOGEN's goal in hosting this event series is to engage our practitioners and clients in healthcare's latest developments," said CEO Brian Blackburn, "Dr. Perlmutter and Dr. Nemiroff are at the top of their respective fields and will no doubt provide an enjoyable and informative experience for our guests."
The Metabolic Nexus runs select weekends starting September 7 through January 19 in numerous cities across the nation. Admission can be reserved online for $189 ($139 for students and staff) at www.xymogen.com/practitioners/metabolic-nexus.aspx
About XYMOGEN
XYMOGEN, a family-owned, health sciences company with headquarters in Orlando, Fla., has been providing high-quality dietary supplements to licensed health care practitioners for more than a quarter century.
The nutraceutical company has introduced numerous innovations to the functional medicine community; its Medical Board of Advisors consists of clinical practitioners who represent a broad range of specialties.
XYMOGEN's strength as a company was reinforced in 2007, 2008, 2010, 2011, 2012 and 2013 when it was recognized by Inc. Magazine as one of the 5,000 fastest-growing, best-run, most innovative and most inspiring private companies in America.
The company's 136,000-square-foot manufacturing facility is GMP (good manufacturing practices) and GMP for Sport Athletic Banned Substances Program registered by NSF International.
More information is available at www.xymogen.com
Please email [email protected] for comments or inquiries.
Distributed by Sara Brady Public Relations, Inc.
222 W. Comstock Avenue, Suite 215
Winter Park, Florida 32789
407-702-6632
www.sarabradypr.com
For information, contact:
Kristin Colville
407-702-6634
SOURCE XYMOGEN
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article